Toxicity of a Novel Herbomineral Preparation Las01 on Human Cancer Cell Lines and Its Safety Profile in Humans and Animals

Table 1

Effect of acute administration of Las01 in rats.

Parameters	Control	Las01
		Group 1	Group 2	Group 3
Total WBCcount × 10^3 mm^3	6293 ± 488	6342 ± 422	6321 ± 230	6234 ± 230
Haemoglobin (gm%)	11.91 ± 1.85	11.82 ± 1.33	11.75 ± 1.0	11.82 ± 1.0
Bilirubin total (mg/dL)	0.31 ± 0.13	0.30 ± 0.12	0.31 ± 0.15	0.32 ± 0.15
Bilirubin direct (mg/dL)	0.24 ± 0.32	0.29 ± 0.27	0.25 ± 0.25	0.27 ± 0.15
SGPT (U/L)	44.8 ± 11.5	45.7 ± 11.1	44.53 ± 12.38	46.11 ± 12.38
SGOT (U/L)	135.4 ± 19.6	139.3 ± 15.26	136.2 ± 17.25	133.4 ± 17.25
ALP (U/L)	161.8 ± 92.1	168.6 ± 93.2	170.7 ± 94.5	163.6 ± 91.5
Albumin (mg/dL)	3.53 ± 0.41	3.35 ± 0.46	3.71 ± 0.32	3.47 ± 0.32
Globulin (mg/dL)	4.03 ± 0.19	4.03 ± 0.36	4.00 ± 0.39	4.12 ± 0.39
Total protein (gm%)	7.56 ± 0.28	7.38 ± 0.22	7.71 ± 0.42	7.59 ± 0.42
BUN (mg/dL)	66.58 ± 7.45	63.13 ± 6.6	66.26 ± 7.48	65.32 ± 7.48
Creatinine (mg/dL)	0.45 ± 0.05	0.46 ± 0.04	0.44 ± 0.04	0.44 ± 0.04
Sodium (mEq/L)	146 ± 4.41	147.5 ± 2.82	144.3 ± 5.6	148.3 ± 5.6
Potassium (mEq/L)	4.15 ± 0.18	4.12 ± 0.39	4.14 ± 0. 23	4.16 ± 0. 23
Chloride (mEq/L)	104 ± 1.18	103 ± 1.68	101.8 ± 3.70	102.9 ± 3.70